Moderna, the U.S. biotechnological company will set the price of vaccination series against Covid-19 at the level of 50-60 dollars. Reuters reported this, noting that the final market price is still up to discussion.
The price offered by the company will be set in the United States and other countries with a high average income level. Thus, Moderna representative claimed that the company is negotiating with governments on possible supplies of the mRNA-1273 vaccine; however, he did not provide any details on prices, taking into account the confidential nature of discussions and contracts.
Currently, 17 vaccines against coronavirus are tested on humans. The most promising one is the vaccine developed by the University of Oxford. It was the first to enter the third phase of clinical research.
Earlier, another vaccine successfully passed the first phase of clinical tests in the U.S.
The WHO hopes that the global vaccination campaign will begin in the middle of 2021.
According to Worldometers, as of early July 29, the number of those who got sick worldwide exceeded 16,900,832.